We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bristol Myers Gains COVID-19 Antibody in Deal With Rockefeller University
Bristol Myers Gains COVID-19 Antibody in Deal With Rockefeller University
Bristol Myers Squibb (BMS) has struck a deal with Rockefeller University for the global rights to a monoclonal antibody being developed by the university to treat COVID-19.